MedPath

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Effect Of Obesity On Ozone-Induced Airway Inflammation

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: ozone, 0.4 ppm
First Posted Date
2009-02-10
Last Posted Date
2012-08-27
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
40
Registration Number
NCT00839943
Locations
🇺🇸

US EPA Human Studies Facility-UNC -CH campus, Chapel Hill, North Carolina, United States

Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans

Not Applicable
Completed
Conditions
Healthy Control
Interventions
Other: ozone
First Posted Date
2009-02-10
Last Posted Date
2017-09-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
84
Registration Number
NCT00840528
Locations
🇺🇸

US EPA Human Studies Facility, Chapel Hill, North Carolina, United States

A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals

Phase 1
Completed
Conditions
Asthma
Hypersensitivity
Interventions
Biological: Clinical Center Reference Endotoxin (CCRE)
First Posted Date
2009-02-09
Last Posted Date
2012-12-05
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
32
Registration Number
NCT00839124
Locations
🇺🇸

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Response of Airway Cells to 20,000 EU of Endotoxin in Normal Adults

Phase 1
Terminated
Conditions
Healthy Controls
Interventions
Biological: Clinical Center Reference Endotoxin (CCRE)
First Posted Date
2009-02-09
Last Posted Date
2012-10-08
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
26
Registration Number
NCT00838851
Locations
🇺🇸

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults

Phase 1
Completed
Conditions
Asthma
Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal
First Posted Date
2009-02-09
Last Posted Date
2009-12-09
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
11
Registration Number
NCT00839189
Locations
🇺🇸

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes

Phase 2
Completed
Conditions
Non Insulin Dependent Diabetes
Pregnancy
Interventions
First Posted Date
2009-02-04
Last Posted Date
2017-04-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
31
Registration Number
NCT00835861
Locations
🇺🇸

University of North Carolina Hospitals Obstetric Clinics, Chapel Hill, North Carolina, United States

In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics

Phase 1
Completed
Conditions
Allergic
Asthmatic
Allergy
Asthma
Interventions
Dietary Supplement: gamma-tocopherol
First Posted Date
2009-02-04
Last Posted Date
2011-11-06
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
25
Registration Number
NCT00836368
Locations
🇺🇸

Center for Environmental Medicine Asthma and Lung Biology, Chapel Hill, North Carolina, United States

A Safety Study of Eptifibatide in Patients With Sickle Cell Disease

Phase 1
Terminated
Conditions
Sickle Cell Disease
Interventions
Drug: Placebo
First Posted Date
2009-02-03
Last Posted Date
2013-06-27
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
13
Registration Number
NCT00834899
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Comparison of Antibiotics for Pseudomonas in Early CF

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2009-01-15
Last Posted Date
2011-04-18
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
21
Registration Number
NCT00823238

Oral Immunotherapy (OIT) for Peanut Allergy

Phase 2
Completed
Conditions
Peanut Hypersensitivity
Interventions
Drug: Placebo
First Posted Date
2008-12-29
Last Posted Date
2018-03-01
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
16
Registration Number
NCT00815035
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath